Option chain shows key data for CalciMedica's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for CalciMedica.

CalciMedica (NASDAQ:CALC) Stock, Option Chain

CalciMedica

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.

CALC


Small-cap stocks are more important than ever. The combined forces of falling interest rates and business-friendly presidential policies are expected to create economic tailwinds in 2025 and a broadening stock market

Insiders Bet Big on These Small Cap Stocks

Carvana

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ATEC

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

CPSH

CVNA

DAWN

EFSH

ELAB

ENSC

LUXH

MDJH

RDDT

RELY

ROKU

ROOT

Why Carvana Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket

I53 Investments Since 2017

Short Ideas

Insider Trades

AULT

ZVIA

Standard BioTools And 2 Other Penny Stocks Executives Are Buying

CalciMedica Inc

Calcitech Ltd

Calcol Inc

Press Releases

CalciMedica Announces Presentations at Upcoming Medical Meetings

CalciMedica to Participate in the Piper Sandler 36th Annual Healthcare Conference

CalciMedica Announces Appointment of Dr. Alan Glicklich to Board of Directors

CalciMedica to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

CalciMedica Announces Upcoming Plenary Presentation at the 30th International AKI & CRRT Conference

CalciMedica Presents AKI Data from a Post-Hoc Analysis of the Phase 2 CARDEA trial of Auxora™ in Severe COVID-19 Pneumonia at the 30th International AKI & CRRT Conference

CalciMedica Secures Credit Facility for Up to $32.5 Million

Earnings

CalciMedica Reports 2024 Financial Results and Provides Clinical & Corporate Updates

CalciMedica to Participate in the Jones Healthcare and Technology Innovation Conference

Aspire Biopharma Holdings, Inc. - Common Stock

Aspire Biopharma Hldgs

Athira Pharma

Cognition Therapeutics, Inc. - Common Stock

Cognition Therapeutics

Cingulate

Cocrystal Pharma

Cadrenal Therapeutics, Inc. - Common Stock

Cadrenal Therapeutics

Dare Bioscience

Durect

Gelteq

Grace Therapeutics

Hoth Therapeutics

IGC Pharma

Jupiter Neurosciences, Inc. - Common Stock

Jupiter Neurosciences

Lexaria Bioscience

Lipocine

MIRA Pharmaceuticals, Inc. - Common Stock

Mira Pharmaceuticals

NRX Pharmaceuticals

Pulmatrix

Rani Therapeutics Holdings, Inc. - Class A Common Stock

Rani Therapeutics Hldgs

Relmada Therapeutics, Inc. - Common Stock

Relmada Therapeutics

Scilex Holding

China SXT Pharmaceuticals, Inc. - Common Stock

China SXT Pharmaceuticals

Talphera

TherapeuticsMD

VYNE Therapeutics

HC Wainwright & Co.

LUCID CAPITAL MARKETS

Oppenheimer

JonesTrading

Comments

CalciMedica

CalciMedica (CALC) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell